SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Digi Power X, Inc. is a block chain technology company, which engages in crypto currency mining. It focuses on validation through mining, hosting solutions, and blockchain software solutions. It operates through the following segments: Cryptocurrency Mining, Sales of Energy and Electricity, and Colocation Services. The company was founded on February 18, 2017, and is headquartered in Miami, FL.

Digi Power X Inc. - Ordinary Shares (Sub voting)

Digi Power X is currently trending as a high-conviction speculative play driven by a billion-dollar colocation contract with Cerebras Systems, positioning it as a key AI infrastructure proxy ahead of the Cerebras IPO. The community is heavily debating the company's growth-focused capital raising strategy versus potential dilution, while retail investors remain focused on the potential for institutional rerating as the company scales its modular data center capacity.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing an intense rally fueled by structural memory shortages and sustained demand for AI infrastructure, leading to widespread community debate over whether the stock is undergoing a long-term rerating or forming a speculative bubble. Investors are actively discussing the impact of supply bottlenecks, potential production strikes, and the company's role as a critical component supplier in the growing AI hardware ecosystem.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is seeing increased market volatility and investor interest as the community weighs strong quarterly results, expansion in Matrix-M licensing agreements, and the potential impact of a cruise ship-related Hantavirus outbreak. While some investors are monitoring the Hantavirus news for a potential sector-wide rally, others remain focused on the company's long-term pivot toward an IP-licensing model and ongoing internal pressure regarding executive leadership.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing heightened volatility and increased trading volume as the community reacts to emerging details about an early-stage hantavirus vaccine program. Investors are actively debating the stock's future, balancing potential pandemic-driven upside against broader biotech sector rotations and upcoming clinical data presentations.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is seeing a surge in retail interest and trading volume as investors connect the company's specialized MRAM technology to broader AI infrastructure and defense sector momentum. The community is actively debating the stock's potential for a significant squeeze, with many comparing its low-float setup and emerging relevance in edge AI to the recent parabolic moves seen in larger semiconductor peers.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as shareholders anticipate potential FDA developments following reports of leadership turmoil at the agency and increased institutional positioning from major firms like Vanguard. The community is actively discussing the stock's significant short interest and potential catalysts, including global expansion and the anticipated filing decision for Anktiva's label expansion.

Chip

Chip is attracting intense community attention as a governance token for a DeFi protocol that enables GPU-backed stablecoin lending, with discussions centering on its potential as infrastructure for the AI compute economy. While some investors are bullish on its real-world utility and massive volume, others warn of high volatility and aggressive insider selling, leading to a polarized environment fueled by both speculation and institutional-grade narrative building.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is trading at a significant discount to its $35 acquisition price due to ongoing community and institutional debate over whether potential regulatory hurdles, such as Israeli government approval or labor strikes, might complicate or delay the merger. Investors remain active in the symbol, weighing the potential for a bidding war or dividend payouts against the risk of deal failure in a volatile shipping environment.

Sun Communities, Inc. provides real estate management services. The firm operates through the following segments: Manufactured Home Communities, Recreational Vehicle, and Marina. The Manufactured Home Communities segment owns, operates, and develops manufactured housing communities and is in the business of acquiring, operating, and developing ground up communities to provide housing solutions. The Recreational Vehicle segment focuses on the development of recreational vehicle resorts and is in the business of acquiring, operating and developing ground up resorts throughout the U.S. and in Ontario, Canada. The Marina segment operates marinas and is in the business of acquiring and operating marinas throughout the U.S. The company was founded in 1975 and is headquartered in Southfield, MI.

Sun Communities, Inc.

Sun Communities is trending as investors react to a tentative settlement regarding a lawsuit that alleged misleading governance and financial disclosures, while the community continues to confuse the REIT with the unrelated blockchain project Sui.

Subsquid Network is an innovative decentralized data lake and query engine designed to offer developers performant and permissionless access to data, aiming to build a neutral and open internet rooted in Web3 principles. Secured by ZK proofs, the Subsquid network boasts a modular architecture that enables exceptional scalability and developer convenience optimized for blockchain indexing, dApp development, and analytics.  Subsquid is a response to unscalable and rigid monolithic indexing frameworks that had previously gained popularity and market traction among Web3 developers. Today, these frameworks are struggling to adapt in a rapidly evolving blockchain environment. Additionally, the network serves as a highly efficient and decentralized alternative to centralized infrastructure firms, including large RPC and API providers.

SQD is trending as the community debates its utility as a decentralized blockchain data indexing layer integrated with Rezolve AI, while simultaneously reacting to recent exchange listings and the launch of new revenue-sharing pools. Investors remain divided, with many highlighting the project's infrastructure role in powering AI-agent commerce, while others express skepticism and frustration over recent price volatility and token performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS The reason for the excitement at the AACR Tuesday session is that SLS009 targets a &quot;Master Switch&quot; that exists in almost all cancer cells, not just leukemia.

Big Pharma suitors like Merck (Keytruda) and Gilead are interested because they know that if you solve the TP53/MCL-1 problem in AML, you have the &quot;Master Key&quot; for the entire oncology market.

If GPS is Batman—the legendary hero holding the &quot;Immune Wall&quot; for years—then SLS009 isn&#39;t some sidekick Robin. It’s more like Superman showing up from another planet.

The Wolf of Finland

Norman Buchanan

EasyLode

Friend

Csaba Bagi

Jorge Lopes

alexsays_

Kovacs Miklos

Cool Moon

Rodolphe Barth

Yung Ceejay

Felix Petri

Geert Langenus

Mario Mahirka

Fausto Rossi

Richard

ICEGIRL

K. estakhr

Jeff Freedman

Webbie

Bradley Johnson

stockphd

Brandon Skelton

Jonathan

Kat Tastrophe

Kevin

StockTwits for iOS

SELLAS Life Sciences Group Inc

 The reason for the excitement at the AACR Tuesday session is that SLS009 targets a "Master Switch" that exists in almost all cancer cells, not just leukemia.

Big Pharma suitors like Merck (Keytruda) and Gilead are interested because they know that if you solve the TP53/MCL-1 problem in AML, you have the "Master Key" for the entire oncology market.

If GPS is Batman—the legendary hero holding the "Immune Wall" for years—then SLS009 isn't some sidekick Robin. It’s more like Superman showing up from another planet.

Outlook Therapeutics Inc

Greenwich LifeSciences Inc

Universe Pharmaceuticals INC

Cingulate Inc

Cardio Diagnostics Holdings Inc

CXApp Inc

DigiAsia Corp

Duncan Teo

@Duncan74 well...if bo happens it will be astonomicly...lifechanging opportunity even with low Investments

Ehrenhardt

Anon

Andy L.

Arturas Paulikas

John Delaney

Stephen

StockTwits For Android 

 well...if bo happens it will be astonomicly...lifechanging opportunity even with low Investments

Galectin Therapeutics Inc

Atossa Therapeutics Inc

Ocugen Inc

Tempest Therapeutics Inc

Marc

@BanannenBernhard Here is how the Justice League takes over the &quot;Universe&quot;:

Batman (GPS): He stays in Gotham (AML) and other &quot;cities&quot; (Ovarian, Mesothelioma), building the Immune Wall. He ensures that once the crime is stopped, it stays stopped. He is the master of the &quot;Long-Term Survival&quot; law.

Superman (SLS009): He doesn&#39;t care about Gotham&#39;s local rules. His TP53-independent killing and MCL-1 Off-Switch are &quot;Universal Powers.&quot; Whether it&#39;s the Pancreatic Galaxy, the Lung Nebula, or the Triple-Negative Breast Star System, he flies in and executes the cancer in 8 hours.

The &quot;Universal&quot; Valuation Reset:
When they fight together, they aren&#39;t just cleaning up a neighborhood; they are establishing a New Standard of Care for the Universe.

Just for Laughs. NFA.

Szepen

Jason Cothern

Daddy

Sergey

mrittika1971

MoonRiderSLS

Ricko4

george Qi

 Here is how the Justice League takes over the "Universe":

Batman (GPS): He stays in Gotham (AML) and other "cities" (Ovarian, Mesothelioma), building the Immune Wall. He ensures that once the crime is stopped, it stays stopped. He is the master of the "Long-Term Survival" law.

Superman (SLS009): He doesn't care about Gotham's local rules. His TP53-independent killing and MCL-1 Off-Switch are "Universal Powers." Whether it's the Pancreatic Galaxy, the Lung Nebula, or the Triple-Negative Breast Star System, he flies in and executes the cancer in 8 hours.

The "Universal" Valuation Reset:
When they fight together, they aren't just cleaning up a neighborhood; they are establishing a New Standard of Care for the Universe.

Just for Laughs. NFA.

@Duncan74 A future combination of SLS009+GPS for a wide range of cancers?

Scott

StockTwits Web

 A future combination of SLS009+GPS for a wide range of cancers?

Abbvie Inc

IO Biotech Inc

MAIA Biotechnology Inc

@GCPA That future belongs to the BP. Ours is in Vegas 24/7 entertainment. Unless of course they include some shares in the buyout package.

 That future belongs to the BP. Ours is in Vegas 24/7 entertainment. Unless of course they include some shares in the buyout package.